Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. .TMU Publications / 北醫出版品(教師升等著作 / 教學實踐 / 學位論文)
  3. .博碩士學位論文
  4. 105學年度
  5. 半夏瀉心湯證之疊方配伍實證研究
 
  • Details
Options

半夏瀉心湯證之疊方配伍實證研究

Other Title
The Evidence-Based Medicine Study on Prescribed Types of Ban-Xia-Xie-Xin-Tang Pattern
Type
thesis
Date Issued
2017-07-07
Author(s)
黃品臻
Advisor
王靜瓊
吳宗修
Subjects
系所名稱:生藥學研究所
Description
學位別:碩士
語文別:中文
指導教授:王靜瓊
共同指導教授:吳宗修
口試委員:許中華;戴承杰;梁文俐
中文關鍵字:半夏瀉心湯;疊方;胃功能性障礙;幽門螺旋桿菌;發炎
英文關鍵字:Ban-Xia-Xie-Xin-Tang;prescription types;disorders of function of stomach;Helicobacter pylori;inflammation
Abstract
半夏瀉心湯是治療消化道疾病的常用處方,亦是調和腸胃的代表方劑。利用健保資料庫分析得知,半夏瀉心湯亦最常用於胃功能性障礙(ICD-9-536),且臨床上有五種常見疊方類型:類型一(T1):半夏瀉心湯,類型二(T2):半夏瀉心湯配伍平胃散,類型三(T3):半夏瀉心湯配伍香砂六君子湯,類型四(T4):半夏瀉心湯配伍保和丸、茯苓、延胡索,類型五(T5):半夏瀉心湯配伍安中散。T1春季用量最多,T3冬季用量最多,T4秋季用量最多。根據臨床研究文獻評讀結果,半夏瀉心湯與香砂六君子湯之實證強度較強,而藥理研究文獻亦顯示,半夏瀉心湯之實證強度最強。綜合上述質性分析顯示,半夏瀉心湯用於消化道疾病具有強的實證。繼而利用基礎實驗探討此五種處方類型對胃保護之作用。結果顯示:對於初代大鼠胃黏膜細胞,半夏瀉心湯、保和丸、茯苓可促進胃黏膜細胞生長。但各中藥及疊方配伍皆不具降低酒精誘導初代大鼠胃黏膜細胞損傷。抑制幽門螺旋桿菌之作用,除半夏瀉心湯外其餘皆有抑制作用,以茯苓之抑菌效果最高,其次為延胡索。而疊方配伍以T2與T4抑菌活性最佳。抗發炎活性,中藥及各疊方皆明顯抑制LPS誘導RAW 264.7細胞釋放NO與PGE2,但以半夏瀉心湯之作用最強。綜合質性分析與基礎實驗結果,推測半夏瀉心湯證為嘔吐、心下痞、腸鳴,與ICD-9診斷胃功能性障礙類似;嘔吐兼有噫氣呑酸、且心下痞更甚有脹滿時,配伍平胃散(T2);腸鳴兼有腹瀉、腹痛,配伍香砂六君子湯(T3);脹滿伴有宿食停積、腹痛者配伍保和丸、茯苓、延胡索(T4);嘔逆甚出現吐酸、脘腹痛者配伍安中散(T5)。各疊方用於胃功能性障礙是透過抗發炎作用。半夏瀉心湯不具抑制胃幽門螺旋桿菌作用故配伍其他中藥以增強作用。由於方劑及疊方的複雜性,半夏瀉心湯與之疊方的實證臨床療效與詳細藥理機制尚待進一步探索深入。
URI
https://203.71.86.71/handle/123456789/57764

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback